Skip to main
UNH

UnitedHealth Group (UNH) Stock Forecast & Price Target

UnitedHealth Group (UNH) Analyst Ratings

Based on 24 analyst ratings
Buy
Strong Buy 25%
Buy 54%
Hold 13%
Sell 8%
Strong Sell 0%

Bulls say

UnitedHealth Group's robust growth is underscored by an anticipated 13% earnings increase in 2026, primarily driven by margin improvements within its Medicare and commercial segments. The Optum division demonstrates strong performance, with Optum Health projected to achieve earnings growth of approximately 9% and expanding margins, which contribute significantly to the company's overall earnings mix. Additionally, UnitedHealth's vertical integration strategy enhances its competitive positioning, as the Optum business effectively complements its core managed care operations, further solidifying its market leadership.

Bears say

UnitedHealth Group is facing a challenging outlook due to projected membership declines across its commercial risk and Medicare Advantage segments, with anticipated losses of 1.3 to 1.4 million members for 2026, significantly impacting revenue and market share. Additionally, the company's Medicaid margins are expected to deteriorate sharply, from a slim profit margin in 2025 to a projected loss of 1.8% in 2026, attributed to job-related Medicaid termination effects and industry-wide pressures on pricing structures. Moreover, the recent announcement of a minimal increase of 0.09% in MA rates for FY2027 contrasts sharply with expectations for mid-single-digit increases, reflecting ongoing regulatory pressure and a potentially unfavorable landscape for future earnings.

UnitedHealth Group (UNH) has been analyzed by 24 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 54% recommend Buy, 13% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of UnitedHealth Group and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About UnitedHealth Group (UNH) Forecast

Analysts have given UnitedHealth Group (UNH) a Buy based on their latest research and market trends.

According to 24 analysts, UnitedHealth Group (UNH) has a Buy consensus rating as of Feb 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $373.12, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $373.12, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

UnitedHealth Group (UNH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.